JRCT ID: jRCT2080224724
Registered date:17/06/2019
A study to assess the safety and efficacy of ZPL389 with concomitant or intermittent use of TCS and/or TCI in atopic dermatitis patients.
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | Atopic dermatitis |
Date of first enrollment | 17/06/2019 |
Target sample size | 36 |
Countries of recruitment | Japan,Asia except Japan,North America,Europe |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : ZPL389 INN of investigational material : - Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational material : ZPL389 once daily control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | safety *Frequency of AEs at Week 32 and Week 116. |
---|---|
Secondary Outcome | efficacy *Investigator's global assessment response.[ Time Frame: Investigator's global assessment rating score up to Week 120 ] *Eczema Area and Severity Index (EASI) score. [ Time Frame: EASI-50/EASI-75 response up to Week 120 ] |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | *Subjects must give a written, signed and dated informed consent *Subjects with atopic dermatitis who have participated in and completed 16 weeks of treatment in CZPL389A2203 study. *Willing and able to comply with scheduled visits, treatment plan, laboratory tests, diary completion and other study procedures. |
Exclude criteria | *Inability to use TCS and/or TCI due to history of important side effects of topical medication (e.g., intolerance or hypersensitivity reactions). *Treatment discontinued subject from CZPL389A2203 study. *Any skin disease that would confound the diagnosis or evaluation of atopic dermatitis disease activity. |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03948334,JapicCTI-194800 |
Contact
Public contact | |
Name | |
Address | |
Telephone | +81-120-003-293 |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | +81-120-003-293 |
Affiliation |